Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | TET2 |
| Variant | R506* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | TET2 R506* results in a premature truncation of the Tet2 protein at amino acid 506 of 2002 (UniProt.org). R506* results in a loss of 5-hydroxymethylcytosine (5hmc) formation in cultured cells (PMID: 24994606), and therefore, is predicted to lead to a loss of Tet2 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
TET2 mutant TET2 inact mut TET2 R506* |
| Transcript | NM_001127208.3 |
| gDNA | chr4:g.105235458A>T |
| cDNA | c.1516A>T |
| Protein | p.R506* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001127208.3 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_047415843.1 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| NM_001127208.2 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_005263082.3 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_024454103.2 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| NM_017628.4 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_006714242 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_024454102.2 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_024454102.1 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_047415839.1 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_047415842.1 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_005263082 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_005263082.4 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_024454103.1 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_006714242.4 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| NM_001127208 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_047415840.1 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| NM_017628.4 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| NM_017628 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_006714242.3 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_017008319.1 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_047415841.1 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_017008319.2 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| XM_017008319 | chr4:g.105235458A>T | c.1516A>T | p.R506* | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|